Invention Grant
- Patent Title: Quinoline compounds
- Patent Title (中): 喹啉化合物
-
Application No.: US12430397Application Date: 2009-04-27
-
Publication No.: US08008306B2Publication Date: 2011-08-30
- Inventor: Minoru Koura , Ayumu Okuda , Takayuki Matsuda , Yuki Yamaguchi , Hisashi Sumida , Sayaka Kurobuchi , Yuichiro Watanabe , Takashi Enomoto , Kimiyuki Shibuya
- Applicant: Minoru Koura , Ayumu Okuda , Takayuki Matsuda , Yuki Yamaguchi , Hisashi Sumida , Sayaka Kurobuchi , Yuichiro Watanabe , Takashi Enomoto , Kimiyuki Shibuya
- Applicant Address: JP Nagoya-shi, Aichi
- Assignee: Kowa Company, Ltd.
- Current Assignee: Kowa Company, Ltd.
- Current Assignee Address: JP Nagoya-shi, Aichi
- Agency: Westerman, Hattori, Daniels & Adrian, LLP
- Main IPC: C07D215/12
- IPC: C07D215/12 ; C07D215/233 ; C07D241/40 ; A61K31/4709 ; A61K31/498
Abstract:
To provide a novel LXRβ agonist that is useful as a preventative and/or therapeutic agent for atherosclerosis; arteriosclerosis such as those resulting from diabetes; dyslipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases that are caused by inflammatory cytokines; skin diseases such as allergic skin diseases; diabetes; or Alzheimer's disease.A quinoline compound represented by the following general formula (1) or salt thereof, or their solvate.
Public/Granted literature
- US20100016327A1 QUINOLINE COMPOUNDS Public/Granted day:2010-01-21
Information query
